{
    "clinical_study": {
        "@rank": "92395", 
        "arm_group": [
            {
                "arm_group_label": "IUGR pregnancies", 
                "description": "Pregnancies complicated with IUGR. Fetal growth beneath the 10th percentile"
            }, 
            {
                "arm_group_label": "pregnancies  with  Gestational   Diabetes", 
                "description": "Normal glucose levels before 20 weeks, and positive Oral glucose tolerance test"
            }, 
            {
                "arm_group_label": "Pre  Gestational   Diabetes", 
                "description": "A diagnosis of Diabetes before pregnancy or elevated glucose levels before 20 weeks."
            }, 
            {
                "arm_group_label": "IVF pregnancies"
            }
        ], 
        "biospec_descr": {
            "textblock": "placental tissue ,fetal cord blood and maternal blood."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Genetic and environmental factors are believed to play a major role in intrauterine growth\n      and intrauterine programming. We intend to study genetic factors such as Telomere\n      homeostasis, senescence, genomic instability and the presence of Genomic copy number\n      variations in placental tissue from pregnancies complicated with Intrauterine growth\n      restriction(IUGR), Gestational and pre gestational  Diabetes, placentas from IVF pregnancies\n      and from  normal pregnancies. We also intend to assess these factors in cord blood and\n      maternal blood."
        }, 
        "brief_title": "The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome", 
        "completion_date": {
            "#text": "September 2023", 
            "@type": "Anticipated"
        }, 
        "condition": "Normal Pregnancies", 
        "condition_browse": {
            "mesh_term": "Metabolic Syndrome X"
        }, 
        "detailed_description": {
            "textblock": "Based on the previous data from our group as well as other laboratories, we postulate that\n      there is a correlation between impaired telomere homeostasis, senescence genomic instability\n      and intra-uterine programming in placentas and in fetuses exposed to suboptimal intrauterine\n      conditions such as hypoxia or hyperglycemia. Improved understanding of the mechanisms that\n      produce the genomic changes in IUGR placentas and their influence on later risks of\n      developing the metabolic syndrome should provide basis for future research that might lead\n      into improved outcome of IUGR fetuses."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A diagnosis of Intrauterine growth restriction\n\n          -  A diagnosis of Gestational diabetes\n\n          -  A diagnosis of  pre gestational  Diabetes\n\n          -  IVF pregnancy\n\n        Exclusion Criteria:\n\n          -  chorioamnionitis\n\n          -  meconium stained amniotic fluid\n\n          -  A request of the patient for Cord blood retrieval for preservation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Samples from pregnancies complicated with IUGR, Gestational and pre gestational  Diabetes,\n        placentas from IVF pregnancies and from  normal pregnancies. We intend to assess these\n        factors in placental tissue, in cord blood and maternal blood."
            }
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883154", 
            "org_study_id": "loe135673ctil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 19, 2013", 
        "location": {
            "contact": {
                "last_name": "Tal Biron Shental, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Kfar Saba", 
                    "country": "Israel"
                }, 
                "name": "Meir medical center"
            }, 
            "investigator": [
                {
                    "last_name": "Rivka Sukenik Halevy, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Tal Biron Shental, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "4", 
        "official_title": "The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome", 
        "overall_contact": {
            "email": "Tal.Biron-Shental@clalit.org.il", 
            "last_name": "Tal Biron Shental, MD", 
            "phone": "972-52-836-2331"
        }, 
        "overall_contact_backup": {
            "email": "riki.sukenik@gmail.com", 
            "last_name": "Rivka Sukenik-Halevy, MD", 
            "phone": "972-52-6007249"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Clalit Health Services", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of Copy Number Variations", 
            "safety_issue": "No", 
            "time_frame": "10 yeras"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883154"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Telomere length", 
                "safety_issue": "No", 
                "time_frame": "10 years"
            }, 
            {
                "measure": "Number of copies of mitochondrial DNA", 
                "safety_issue": "No", 
                "time_frame": "10 years"
            }
        ], 
        "source": "Meir Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meir Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}